- 12/18 - KALYPSYS INITIATES PHASE IIA CLINICAL TRIAL OF TOPICAL INOS INHIBITOR
- 04/16 - KALYPSYS INITIATES SECOND PHASE I CLINICAL TRIAL OF TOPICAL INOS INHIBITOR
- 11/29 - KALYPSYS RAISES $100 MILLION IN A SERIES C FINANCING
- 09/26 - KALYPSYS ON TRACK TO COMPLETE PHASE IA STUDY FOR DRUG CANDIDATE, KD3010, FOR METABOLIC DISORDERS BY END OF OCTOBER
- 09/20 - KALYPSYS APPOINTS 2 EXECUTIVES TO LEADERSHIP TEAM
- 09/08 - PANASONIC AND KALYPSYS COLLABORATE FOR DEVELOPMENT OF DRUG DISCOVERY SYSTEMS
- 01/04 - KALYPSYS ANNOUNCES SMALL MOLECULE RESEARCH COLLABORATION WITH ALCON
